The goals of this project are to apply protein chemistry to enhance our understanding of the nature of the crystallized form of hCG, to produce a properly folded hCG receptor fragment for three dimensional studies, and to determine the structures in serum and urine of hCG metabolites useful for diagnosis of diseases of reproduction. Hormone metabolic products have been shown to vary in pathological states and we intend to define the structures of such metabolites to improve their measurement and the understanding of their relationship to normal and abnormal physiology. This project combines our chemical capabilities to purify and structurally analyze minute quantities of proteins with our ability to develop and apply assays for measurement of these proteins. One major theme of this program is the collaborative studies with Projects II and III in an effort to produce properly-folded extracellular CG receptors for studies of the structure of the hormone-receptor interface. A second major theme is to determine the structures of hCG and hLH metabolites as markers of normal pregnancy, diseases of pregnancy and menopause. A third is to develop a nonhuman primate model of early pregnancy loss, EPL (loss of a chemically-detected pregnancy without any clinical evidence of pregnancy). The latter problem, resulting in a decline in human fertility, is a major social concern since it can result from exposure to environmental toxins.
Our specific aims are to: (1) Perform Protein Chemical Studies Related to the Three-Dimensional Structures of the Gonadotropins and Their Receptors; (2) Isolate and determine the structures of forms of hCG and hLH from normal pregnant women, women with ectopic pregnancies, women undergoing ovulation induction and postmenopausal women; and (3) Develop and employ a primate model for the study of reproductive toxicology.

Project Start
1998-01-01
Project End
1999-12-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
17
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Birken, S; Krichevsky, A; O'Connor, J et al. (1999) Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: generation of antibodies that differentiate between pregnancy hCG and choriocarcinoma hCG. Endocrine 10:137-44
Kovalevskaya, G; Birken, S; Kakuma, T et al. (1999) Early pregnancy human chorionic gonadotropin (hCG) isoforms measured by an immunometric assay for choriocarcinoma-like hCG. J Endocrinol 161:99-106
Lin, W; Ransom, M X; Myers, R V et al. (1999) Addition of an N-terminal dimerization domain promotes assembly of hCG analogs: implications for subunit combination and structure-function analysis. Mol Cell Endocrinol 152:91-8
Kovalevskaya, G; Birken, S; Kakuma, T et al. (1999) Evaluation of nicked human chorionic gonadotropin content in clinical specimens by a specific immunometric assay. Clin Chem 45:68-77
Ulaner, G A; Chuang, J; Lin, W et al. (1999) Desensitization and resensitization of lutropin receptors expressed in transfected Y-1 adrenal cells. J Endocrinol 163:289-97
O'Connor, J F; Kovalevskaya, G; Birken, S et al. (1998) The expression of the urinary forms of human luteinizing hormone beta fragment in various populations as assessed by a specific immunoradiometric assay. Hum Reprod 13:826-35
Lunardi-Iskandar, Y; Bryant, J L; Blattner, W A et al. (1998) Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease. Nat Med 4:428-34
Elliott, M M; Kardana, A; Lustbader, J W et al. (1997) Carbohydrate and peptide structure of the alpha- and beta-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine 7:15-32
Campbell, R K; Bergert, E R; Wang, Y et al. (1997) Chimeric proteins can exceed the sum of their parts: implications for evolution and protein design. Nat Biotechnol 15:439-43
Cosowsky, L; Lin, W; Han, Y et al. (1997) Influence of subunit interactions on lutropin specificity. Implications for studies of glycoprotein hormone function. J Biol Chem 272:3309-14

Showing the most recent 10 out of 70 publications